DealPilot organizes content by role, stage, and resource type
See how AI builds personalized learning paths based on your role and timeline
Scale your M&A operating standard across your entire deal team
Learn from and get certified by deal leaders who've run acquisitions themselves.
Kison will be discussing how to foster and maintain good relationships with deal targets.
Kison will be talking to Brett Shawn, Senior Vice President, Assistant General Counsel at Warburg Pincus LLC to discuss how M&A is executed from the legal perspective. They'll be covering minority deals, the different types of risks you are looking for in a deal-and how to mitigate them including COVID-19 related risks.
In this episode, Andrew shares why the legal team's involvement early in the deal process is important and the different key milestones in a deal they are responsible for. He also talks about the dangers of deal fever, working with corporate development teams, and more.
Keeping business leaders motivated and accountable for the deal post-close can be a difficult task. Ensure you have very realistic expectations around financial performance and operational goals so that they take the business case seriously. Hear from two industry experts on how you can incentivize business leaders to stay focused and retaining deal value.
Clayton Stanley, Vice President and Head of Corporate Development at AmeriVet Veterinary Partners, talks about how to make the JV model work on scale and figuring out the right size of the M&A team. Learn about how you can create a joint venture model that is scalable and the prioritization of tasks.
This episode of the M&A Science podcast features our friends over at Cisco. In this interview, we talked about evolving to Agile M&A at scale, with Ashley Rice, Sr. Consultant HR M&A at Cisco, and Kimberly Baird, Corporate Development Integration Lead at Cisco.
Kison interviews Matt Arsenault, Vice President of Corporate Development at Jamf, about the many career paths you can take in M&A. Learn how to shift career path gears, roles to look for when transitioning, and what the future of a corporate development role may look like.
This episode is a session from our Holiday Summit last December with Emma Barton, Director, Alliance and Integration Management at AstraZeneca. We're talking about the spectrum of deals corporate development manages approaching partnerships and alliances and how those relationships may progress into M&A.
This episode of M&A Science is a session from the M&A Science Holiday Summit last year. The interview featured Carlos Cesta, Vice President of Corp Dev at Presidio discussed the best practices to capture value from initial deal prospecting to integration.
Kison sits down with John Orbe, Associate General Counsel - M&A at Emerson to talk about corporate VC deals, what the process looks like, and how to navigate challenges you may encounter.
Join Kison on this interview with Jerry Will, former Vice President of Corporate Development at 3M. We'll be learning about managing a multi-vertical M&A strategy through continuous improvement and leadership development.
Join Kison and Elena Sidelnikova, former Head of Finance and Corporate Development/M&A, CFO at Always Compassionate Home Care, for an interview about how to identify risks in software M&A.
Kison interviews Gina Sandon, Director, Corporate Development, Merger & Acquisitions Synergy, Integration and Transition at IBM, about how to evolve your M&A workflow using Agile principles.
The partnership between the investment sponsor and the operating sponsor needs to be symbiotic to fully align both sides and help each other make the right decisions on deals. Learn how do these sponsors support each other through a transaction in this episode.
On this episode on M&A Science, Kison speaks with Isaac Lund, VP Corporate Development and M&A at National Express LLC. The topic is all about learning how to work with a private seller to get the best outcome.
Teams are trying to figure out how to modernize IMO, and how to build a synergy plan that actually delivers. In this session, Jonathan and Bill discuss bench strength, creating the right IMO team, tips for modernizing, and more.
M&A is not a strategy, rather a tool that can achieve a company's objectives. Learn how to differentiate between using M&A as a tool rather than a strategy, and upon doing that, how to create an appropriate strategy for your process.
Not every company uses the same method for valuation. In this session, Brian Buchert gives some insight to his team's valuation "secret sauce".
_Easy-Resize.com.avif)
_Easy-Resize.com.avif)
_Easy-Resize.com.avif)
_Easy-Resize.com.avif)
_Easy-Resize.com.avif)
%20(1)_Easy-Resize.com.avif)
_Easy-Resize.com.avif)
